Outrage grows as CDC reportedly poised to fund "unethical" vaccine trial

Key points

• Staff at the US Centers for Disease Control and Prevention reportedly asked for $1.6 million to fund a hepatitis B vaccine trial in Guinea-Bissau. The trial was suspended in January after criticism of its design.
• It would give some newborns no birth dose of the vaccine, and the World Health Organization has called withholding it unethical. The trial is on hold pending final approval from Guinea-Bissau officials.
• Stand Up for Science has vowed to block it, calling it a serious ethical breach.